Participants 546 754 7
665 patients with a history of colorectal adenomas to three treatment groups, in a parallel design: calcium gluconolactate and carbonate (2 g elemental calcium daily), fibre (3.5 g ispaghula husk), or placebo
Participants 904 1039 6
23 patients died, 15 were lost to follow-up, 45 refused repeat colonoscopy, and five developed severe contraindications to colonoscopy.
Participants 1050 1134 6
552 participants who completed the follow-up examination, 94 stopped treatment early
Participants 1170 1300 5
28 (15.9%) of 176 patients in the calcium group, 58 (29.3%) of 198 in the fibre group, and 36 (20.2%) of 178 in the placebo group.
Participants 1803 1844 4
patients with high dietary calcium intake
